SMi are proud to present their 7th annual Parallel Trade conference. Our 2013 agenda will showcase the latest developments in pharmaceutical Parallel Trade, looking at the industry’s rapid expansion and latest arguments from key opinion leaders on this controversial industry. Hear from experts in leading industry sectors; see how big Pharma companies are beginning to combat traders and attempt to prevent counterfeit medicines entering the market. Through case studies see how trading can affect future R&D pipelines in big pharma drug development. Parallel trade has unique, important legal issues attached to it – hear from specialist pharmaceutical lawyers explaining issues with intellectual property and specific aspects of repackaging.

Reasons why you should attend:
• Hear from the industry leaders on both the advantages and disadvantages to patients, drug producers and traders. How does trading affect your business – New market access or potential hazard?
• See how parallel trade is being maintained from both sides of the fence, supply chain protection and specific aspects of repackaging.
• Learn how the financial euro crisis has allowed an increase in need for more affordable drugs to supply harder hit countries but also put an increased pressure on pharmaceutical companies who pay for drug development